Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations.

Schneider SA, Talelli P, Cheeran BJ, Khan NL, Wood NW, Rothwell JC, Bhatia KP.

Mov Disord. 2008 Oct 15;23(13):1812-9. doi: 10.1002/mds.22025.

PMID:
18759365
2.

Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys.

McCormack AL, Mak SK, Shenasa M, Langston WJ, Forno LS, Di Monte DA.

J Neuropathol Exp Neurol. 2008 Aug;67(8):793-802. doi: 10.1097/NEN.0b013e318180f0bd.

3.

Modification of bacterial artificial chromosomes (BACs) and preparation of intact BAC DNA for generation of transgenic mice.

Gong S, Yang XW.

Curr Protoc Neurosci. 2005 May;Chapter 5:Unit 5.21. doi: 10.1002/0471142301.ns0521s31.

PMID:
18428623
4.

An overview on the generation of BAC transgenic mice for neuroscience research.

Yang XW, Gong S.

Curr Protoc Neurosci. 2005 May;Chapter 5:Unit 5.20. doi: 10.1002/0471142301.ns0520s31. Review.

PMID:
18428622
5.

In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?

Chesselet MF.

Exp Neurol. 2008 Jan;209(1):22-7. Epub 2007 Aug 23. Review.

6.

Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles.

Hagenah JM, König IR, Becker B, Hilker R, Kasten M, Hedrich K, Pramstaller PP, Klein C, Seidel G.

J Neurol. 2007 Oct;254(10):1407-13. Epub 2007 Oct 15.

PMID:
17934880
7.

Parkinson's disease.

Thomas B, Beal MF.

Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R183-94. Review.

PMID:
17911161
8.

Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression.

Fernagut PO, Hutson CB, Fleming SM, Tetreaut NA, Salcedo J, Masliah E, Chesselet MF.

Synapse. 2007 Dec;61(12):991-1001.

9.

Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia.

Binkofski F, Reetz K, Gaser C, Hilker R, Hagenah J, Hedrich K, van Eimeren T, Thiel A, Büchel C, Pramstaller PP, Siebner HR, Klein C.

Neurology. 2007 Aug 28;69(9):842-50.

PMID:
17724286
10.

Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D.

Takahashi M, Ko LW, Kulathingal J, Jiang P, Sevlever D, Yen SH.

Eur J Neurosci. 2007 Aug;26(4):863-74.

PMID:
17714183
11.

Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities.

Wang C, Lu R, Ouyang X, Ho MW, Chia W, Yu F, Lim KL.

J Neurosci. 2007 Aug 8;27(32):8563-70.

12.

Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration.

Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebrooke RE, Di Monte DA, Emson PC, Miller GW.

J Neurosci. 2007 Jul 25;27(30):8138-48.

13.

Deciphering the role of heterozygous mutations in genes associated with parkinsonism.

Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE.

Lancet Neurol. 2007 Jul;6(7):652-62. Review.

PMID:
17582365
14.

Analysis of dopamine transporter gene expression pattern -- generation of DAT-iCre transgenic mice.

Turiault M, Parnaudeau S, Milet A, Parlato R, Rouzeau JD, Lazar M, Tronche F.

FEBS J. 2007 Jul;274(14):3568-77. Epub 2007 Jun 12.

15.

Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling.

Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE, Wegener E, Nakaso K, Culmsee C, Berninger B, Krappmann D, Tatzelt J, Winklhofer KF.

J Neurosci. 2007 Feb 21;27(8):1868-78.

16.

Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system.

Kramer ER, Aron L, Ramakers GM, Seitz S, Zhuang X, Beyer K, Smidt MP, Klein R.

PLoS Biol. 2007 Mar;5(3):e39.

17.

A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine.

Sang TK, Chang HY, Lawless GM, Ratnaparkhi A, Mee L, Ackerson LC, Maidment NT, Krantz DE, Jackson GR.

J Neurosci. 2007 Jan 31;27(5):981-92.

18.

Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons.

Ekstrand MI, Terzioglu M, Galter D, Zhu S, Hofstetter C, Lindqvist E, Thams S, Bergstrand A, Hansson FS, Trifunovic A, Hoffer B, Cullheim S, Mohammed AH, Olson L, Larsson NG.

Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1325-30. Epub 2007 Jan 16.

19.

Genetics of Parkinson's disease and parkinsonism.

Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A.

Ann Neurol. 2006 Oct;60(4):389-98. Review.

PMID:
17068789
20.

Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism.

Lesage S, Magali P, Lohmann E, Lacomblez L, Teive H, Janin S, Cousin PY, Dürr A, Brice A; French Parkinson Disease Genetics Study Group.

Hum Mutat. 2007 Jan;28(1):27-32.

PMID:
17068781

Supplemental Content

Support Center